155 related articles for article (PubMed ID: 8144913)
1. Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.
Tilg H; Shapiro L; Vannier E; Poutsiaka DD; Trehu E; Atkins MB; Dinarello CA; Mier JW
J Immunol; 1994 Mar; 152(6):3189-98. PubMed ID: 8144913
[TBL] [Abstract][Full Text] [Related]
2. Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.
Tilg H; Shapiro L; Atkins MB; Dinarello CA; Mier JW
J Immunol; 1993 Sep; 151(6):3299-307. PubMed ID: 8397255
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
5. Crystal-induced neutrophil activation. V. Differential production of biologically active IL-1 and IL-1 receptor antagonist.
Roberge CJ; de Médicis R; Dayer JM; Rola-Pleszczynski M; Naccache PH; Poubelle PE
J Immunol; 1994 Jun; 152(11):5485-94. PubMed ID: 8189066
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
7. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils.
Marie C; Pitton C; Fitting C; Cavaillon JM
Cytokine; 1996 Feb; 8(2):147-51. PubMed ID: 8777273
[TBL] [Abstract][Full Text] [Related]
8. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ
J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219
[TBL] [Abstract][Full Text] [Related]
9. HIV predominantly induces IL-1 receptor antagonist over IL-1 synthesis in human primary monocytes.
Zavala F; Rimaniol AC; Boussin F; Dormont D; Bach JF; Descamps-Latscha B
J Immunol; 1995 Sep; 155(5):2784-93. PubMed ID: 7650404
[TBL] [Abstract][Full Text] [Related]
10. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
11. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
Xing L; Remick DG
Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362
[TBL] [Abstract][Full Text] [Related]
12. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
[TBL] [Abstract][Full Text] [Related]
13. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.
Jungo F; Dayer JM; Modoux C; Hyka N; Burger D
Cytokine; 2001 Jun; 14(5):272-82. PubMed ID: 11444907
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.
Marsh CB; Wewers MD
Am J Respir Cell Mol Biol; 1994 May; 10(5):521-5. PubMed ID: 8179914
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans.
Bargetzi MJ; Lantz M; Smith CG; Torti FM; Olsson I; Eisenberg SP; Starnes HF
Cancer Res; 1993 Sep; 53(17):4010-3. PubMed ID: 8395334
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
Dinarello CA
Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757
[TBL] [Abstract][Full Text] [Related]
18. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
Higgins GC; Wu Y; Postlethwaite AE
J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
[TBL] [Abstract][Full Text] [Related]
19. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma.
O'Nualláin EM; Puri P; Mealy K; Reen DJ
Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873
[TBL] [Abstract][Full Text] [Related]
20. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
